Karyopharm Therapeutics Inc.
$1.54
-$0.06 (-3.75%)
$1.52Day Range$1.70
Key Statistics
Market Cap
$34.93M
Shares Outstanding
22.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 6, 2013
Round Lot
100
Locale
US
Trading Data
Day Open
$1.59
Day High
$1.70
Day Low
$1.52
Volume
1.33M
VWAP
$1.62
Prev Close
$1.60
Transactions
--
Acc. Volume
--
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
PHARMACEUTICAL PREPARATIONSSIC 2834228 employees85 WELLS AVENUE, NEWTON, MA, 02459617-658-0600IPO Nov 6, 2013US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001503802
- Composite FIGI
- BBG001J272L7
- Share Class FIGI
- BBG001V0G6X5
- Ticker Root
- KPTI
- SIC Code
- 2834
About Karyopharm Therapeutics Inc. (KPTI) Stock
Karyopharm Therapeutics Inc. (KPTI) closed the 2026-09-15 session at $1.54, down 3.75% versus the previous close (-0.06). The stock opened at $1.59 and traded between $1.52 and $1.70 during that session. Session trading volume was 1.3M shares. The volume-weighted average price (VWAP) is $1.62.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Karyopharm Therapeutics Inc. has a market capitalization of $34.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. KPTI is listed on the XNAS exchange. The company employs approximately 228 people. Karyopharm Therapeutics Inc. is headquartered in NEWTON, MA. The recorded listing date is 2013-11-06.
On this page you can find market KPTI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.